NP

Naveen Puri

Active Director Director DIN 08624834
DIN 08624834 First appointment Nov 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Naveen Puri

Data last updated:

Naveen Puri is a Director at Trichoderm India Private Limited (since 2019). The company operates in Pharma. Trichoderm India Private Limited reported revenue of ₹1.42 Cr (FY 2024).

DIN 08624834
Primary Designation Director
Industry Pharma
First Appointment 28 Nov 2019
Oldest Company Age 6 yrs
Largest company Trichoderm India Private Limited · ₹1.42 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trichoderm India Private Limited U33119DL2019PTC358152
Director28 Nov 20192019₹1.42 Cr (FY 2024)Active

Board colleagues of Naveen Puri

NameDINCompanyDesignation
Suruchi Puri08624835Trichoderm India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Trichoderm India Private Limited
Premium access

Shareholding and investment profile for Naveen Puri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveen Puri

Naveen Puri currently holds 1 directorship: Trichoderm India Private Limited (Director, since 28 Nov 2019, revenue ₹1.42 Cr (FY 2024)).

Naveen Puri was first appointed on 28 Nov 2019 as Director at Trichoderm India Private Limited.

The current boards of Naveen Puri's companies include Suruchi Puri (Trichoderm India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available